These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Salmonella dublin enteric fever in two compromised hosts]. Hemmer RJ; Schneider F; Dicato M; Hentges F Pathol Biol (Paris); 1982 Jun; 30(6 Pt 2):560-2. PubMed ID: 6750525 [TBL] [Abstract][Full Text] [Related]
4. Norfloxacin versus co-trimoxazole in the treatment of recurring urinary tract infections in men. Sabbaj J; Hoagland VL; Cook T Scand J Infect Dis Suppl; 1986; 48():48-53. PubMed ID: 3490684 [TBL] [Abstract][Full Text] [Related]
5. Failure of norfloxacin to eradicate intestinal colonization of non-typhoidal salmonella in infants. Sirinavin S; Phuapradit P J Med Assoc Thai; 1989 Jan; 72 Suppl 1():183-6. PubMed ID: 2732641 [TBL] [Abstract][Full Text] [Related]
6. [Comparative efficacy of ampicillin, chloramphenicol, cefotaxime, ceftriaxone and pefloxacin in experimental Salmonella typhimurium infection]. Nauciel C; Martin E Pathol Biol (Paris); 1987 Nov; 35(9):1239-42. PubMed ID: 3320900 [TBL] [Abstract][Full Text] [Related]
7. A multicenter comparative trial of three-day norfloxacin vs ten-day sulfamethoxazole and trimethoprim for the treatment of uncomplicated urinary tract infections. Stein GE; Mummaw N; Goldstein EJ; Boyko EJ; Reller LB; Kurtz TO; Miller K; Cox CE Arch Intern Med; 1987 Oct; 147(10):1760-2. PubMed ID: 3310941 [TBL] [Abstract][Full Text] [Related]
8. Ciprofloxacin and norfloxacin, two fluoroquinolone antimicrobials. Nix DE; DeVito JM Clin Pharm; 1987 Feb; 6(2):105-17. PubMed ID: 3311572 [TBL] [Abstract][Full Text] [Related]
9. Fleroxacin versus norfloxacin for oral treatment of serious urinary tract infections. Childs SJ Am J Med; 1993 Mar; 94(3A):105S-107S. PubMed ID: 8452164 [TBL] [Abstract][Full Text] [Related]
10. Salmonella infections in patients with acquired immunodeficiency syndrome. Profeta S; Forrester C; Eng RH; Liu R; Johnson E; Palinkas R; Smith SM Arch Intern Med; 1985 Apr; 145(4):670-2. PubMed ID: 3885890 [TBL] [Abstract][Full Text] [Related]
11. World-wide clinical experience with norfloxacin: efficacy and safety. Wang C; Sabbaj J; Corrado M; Hoagland V Scand J Infect Dis Suppl; 1986; 48():81-9. PubMed ID: 3535057 [TBL] [Abstract][Full Text] [Related]
12. Comparison of short-term treatment regimen of ciprofloxacin versus long-term treatment regimens of trimethoprim/sulfamethoxazole or norfloxacin for uncomplicated lower urinary tract infections: a randomized, multicentre, open-label, prospective study. Arredondo-García JL; Figueroa-Damián R; Rosas A; Jáuregui A; Corral M; Costa A; Merlos RM; Ríos-Fabra A; Amábile-Cuevas CF; Hernández-Oliva GM; Olguín J; Cardeñosa-Guerra O; J Antimicrob Chemother; 2004 Oct; 54(4):840-3. PubMed ID: 15347634 [TBL] [Abstract][Full Text] [Related]
13. Norfloxacin and azithromycin for treatment of nontyphoidal salmonella carriers. Sirinavin S; Thavornnunth J; Sakchainanont B; Bangtrakulnonth A; Chongthawonsatid S; Junumporn S Clin Infect Dis; 2003 Sep; 37(5):685-91. PubMed ID: 12942401 [TBL] [Abstract][Full Text] [Related]
14. Norfloxacin treatment of salmonellosis does not shorten the carrier stage. Carlstedt G; Dahl P; Niklasson PM; Gullberg K; Banck G; Kahlmeter G Scand J Infect Dis; 1990; 22(5):553-6. PubMed ID: 2259863 [TBL] [Abstract][Full Text] [Related]
15. [Clinical evaluation of norfloxacin preparation in treatment of bacterial infections of the urinary tract in patients with various kidney diseases]. Mazanowska O; Boratyńska M; Mróz E; Starek J Pol Tyg Lek; 1994 Feb 7-14; 49(6-7):154-7. PubMed ID: 8090671 [TBL] [Abstract][Full Text] [Related]